Analysis Taki Chemical Co., Ltd. (4025)
5/30/2024
Analysis of Taki Chemical Co., Ltd. (4025)
Taki Chemical Co., Ltd. seems to be a company involved in the chemical industry based on the name. Looking at the financial data provided, we can see that the stock symbol is 4025. Here is a brief analysis based on the recent data:1. Price Movement:
- The stock price has been fluctuating between 3830.00000 and 4065.00000 over the past few days.
- The closing prices have ranged from 3895.00000 to 3960.00000.
2. Technical Indicators:
- RSI Indicator: The Relative Strength Index (RSI) values have been fluctuating around 50, indicating a balanced market sentiment.
- MACD Indicator: The Moving Average Convergence Divergence (MACD) values have shown some volatility, with the MACD line crossing above and below the signal line.
3. Moving Averages:
- Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) have been calculated for the closing prices. These moving averages can help identify trends and potential support/resistance levels.
4. Overall:
- The stock seems to be trading in a range-bound pattern with no clear trend direction.
- Traders and investors may need to wait for a clearer signal from the technical indicators before making any trading decisions.
Please note that this analysis is based on the provided data and should be supplemented with additional research before making any investment decisions.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The company's financials show a strong cash flow, with operating cash flow at $110.56 billion and levered free cash flow at $84.73 billion. The balance sheet indicates a total cash of $67.15 billion and total debt of $104.59 billion, resulting in a current ratio of 1.037. The company has a book value per share of $4.837 and total cash per share of $4.379, with a total debt to equity ratio of 140.968.In terms of profitability, the company has a profit margin of 26.31% and an operating margin of 30.74%. The return on assets is 22.07% and the return on equity is 147.25%. The most recent quarter ended on March 31, 2024, and the fiscal year ends on September 30, 2023.
From the income statement, we see that the company generated $381.62 billion in revenue, with a gross profit of $169.14 billion and EBITDA of $131.39 billion. The diluted earnings per share stand at $6.43, and the net income to common shareholders is $100.39 billion. The company experienced a negative quarterly revenue growth of -4.3% and a negative quarterly earnings growth year-over-year of -2.2%.
Moving on to stock statistics, the company has a short ratio of 1.53 and a float of 15.31 billion shares. The shares outstanding are 15.33 billion, with 99.29 million shares being shorted. Insiders hold 5.22% of shares, while institutions hold 57.59%. The short percent of shares outstanding is 0.65%.
In terms of valuation metrics, the company has a PEG ratio of 26.32, a forward P/E of 26.32, and a trailing P/E of 29.59. The enterprise value is $2.95 trillion, with a price to book ratio of 39.34 and a price to sales ratio of 7.65. The enterprise is valued at 22.76 times EBITDA and 7.73 times revenue, with a market capitalization of $2.92 trillion.
The stock price summary shows a beta of 1.264, with a 50-day moving average of $176.26 and a 200-day moving average of $181.04. The 52-week low and high prices are $164.08 and $199.62, respectively, resulting in a 52-week change of 6.85%.
Lastly, in terms of dividends and splits, the company has a payout ratio of 14.93% and a forward annual dividend rate of $1. The ex-dividend date is May 10, 2024, with a dividend date of May 16, 2024. The last split date was on August 31, 2020, with a 4-for-1 split. The 5-year average dividend yield is 0.73%, while the trailing annual dividend yield is 0.51%.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, such as net income and operating income, the trend in revenue growth has been positive.
3. The company seems to be effectively generating sales and increasing its top line, which is a good sign for its overall financial health and market position.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets fluctuate, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has been fluctuating, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year's quarter. The estimates range from $1.44 to $1.63, based on projections from 25 analysts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates for the full year range from $6.43 to $6.92, with insights provided by 39 analysts.
4. Moving on to the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, compared to the previous year's EPS of $6.59. The EPS estimates for the upcoming year range from $6.40 to $7.90, based on forecasts from 39 analysts.
Overall, the analysts are generally optimistic about the company's future earnings, with projected increases in EPS for both the current and next fiscal years compared to the respective previous periods.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $83,776,900,000
- Low Estimate: $81,952,300,000
- High Estimate: $85,372,700,000
- Sales Growth: 2%
- Year Ago Sales: $81,797,000,000
- Number of Analysts: 24
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $92,375,300,000
- Low Estimate: $88,180,500,000
- High Estimate: $98,453,000,000
- Sales Growth: 3%
- Year Ago Sales: $89,498,000,000
- Number of Analysts: 24
3. Current Year (as of September 30, 2024):
- Average Estimate: $386,681,000,000
- Low Estimate: $382,010,000,000
- High Estimate: $393,732,000,000
- Sales Growth: 1%
- Year Ago Sales: $383,285,000,000
- Number of Analysts: 37
4. Next Year (as of September 30, 2025):
- Average Estimate: $411,555,000,000
- Low Estimate: $382,083,000,000
- High Estimate: $436,000,000,000
- Sales Growth: 6%
- Year Ago Sales: $386,681,000,000
- Number of Analysts: 37
Based on these estimates, we can see a projected growth in sales for both the current and next quarters, as well as for the current and next year. The company is expected to experience a steady increase in sales, with higher growth rates forecasted for the upcoming year.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
It can be observed that the company is expected to experience a significant decrease in growth rate from the past 5 years to the next 5 years. However, there is a slight increase in growth rate expected in the short term (next quarter and next year) compared to the current period.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.
MACD of 4025
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
